ReachMD

Popular

• 

  RestartResume

  A Look at the Numbers: Cost of Durable Treatments in Retinal Disease

  MinuteCE®

  A Look at the Numbers: Cost of Durable Treatments in Retinal Disease

  • 

    

    Jayanth Sridhar, MD

    Peer

  • 

    

    Sabin Dang, MD

    Peer

  1.00 program credits

• 

  RestartResume

  From Monoamines to Neurocircuits: Our Evolving Understanding of Depression

  Medical Industry Feature

  From Monoamines to Neurocircuits: Our Evolving Understanding of Depression

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

    Peer

  • 

    

    Joseph F. Goldberg, MD

    Peer

• 

  RestartResume

  Reconsidering the Algorithm: Treatment-Resistant DME

  MinuteCE®

  Reconsidering the Algorithm: Treatment-Resistant DME

  • 

    

    Durga Borkar, MD, MMCi

    Peer

  • 

    

    Christina Y. Weng, MD, MBA

    Peer

  1.00 program credits

• 

  RestartResume

  From Heterogeneity Comes New Insights: Exploring the Role of T Cells & OX40 Signaling in Atopic Dermatitis

  Medical Industry Feature

  From Heterogeneity Comes New Insights: Exploring the Role of T Cells & OX40 Signaling in Atopic Dermatitis

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

    Peer

  • 

    

    Jonathan Silverberg, MD, PhD, MPH

    Peer

• 

  RestartResume

  Digital Mental Health Treatments, Part 2: Utilizing Neuroplasticity in Digital Therapies

  Medical Industry Feature

  Digital Mental Health Treatments, Part 2: Utilizing Neuroplasticity in Digital Therapies

  • 

    

    Mark Tacelosky, PharmD

    Peer

  • 

    

    Robin Nelson, MD

    Peer

  • 

    

    Sandeep Vaishnavi, MD, PhD

    Peer

• 

  RestartResume

  Equity in Flu Vaccine Rates: Bridging Racial & Ethnic Gaps

  VacciNation

  Equity in Flu Vaccine Rates: Bridging Racial & Ethnic Gaps

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

    Peer

  • 

    

    Keith C. Ferdinand, MD, FACC, FAHA, FASPC, FNLA

    Peer

• 

  RestartResume

  Managing the Toll of Influenza on Health Systems: Challenges & Strategies

  VacciNation

  Managing the Toll of Influenza on Health Systems: Challenges & Strategies

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

    Peer

  • 

    

    John J. Russell, MD

    Peer

  • 

    

    Darvin Scott Smith, MD

    Peer

• 

  RestartResume

  Achieving Success in IgAN & FSGS

  CME/CE

  Achieving Success in IgAN & FSGS

  • 

    

    Siân Griffin, MD, PhD

    Peer

  • 

    

    Jürgen Floege, MD

    Peer

  • 

    

    Loreto Gesualdo, MD, FERA

    Peer

  0.25 credits

• 

  RestartResume

  Understanding the Fine Print: The Who, When, And What To Do About ARIA in Patients with Alzheimer’s Disease – Primary Care Module

  CME/CE

  Understanding the Fine Print: The Who, When, And What To Do About ARIA in Patients with Alzheimer’s Disease – Primary Care Module

  • 

    

    James Galvin, MD, MPH, FANA

    Peer

  • 

    

    Jon Toledo, MD, PhD

    Peer

  • 

    

    Charles P. Vega, MD

    Peer

  0.50 credits

• 

  RestartResume

  Examining Real-World Evidence on Flu Vaccine Effectiveness

  VacciNation

  Examining Real-World Evidence on Flu Vaccine Effectiveness

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

    Peer

  • 

    

    Darvin Scott Smith, MD

    Peer

• 

  RestartResume

  Bridging the Gap to Care: What You Need to Know About ATTR-CM Amyloidosis

  CME/CE

  Bridging the Gap to Care: What You Need to Know About ATTR-CM Amyloidosis

  • 

    

    Mazen Hanna, MD

    Peer

  • 

    

    Marianna Fontana, MD

    Peer

  0.25 credits

• 

  RestartResume

  What Is the Totality of Evidence for IV Iron Treatment Outcomes in Patients with Heart Failure?

  CME/CE

  What Is the Totality of Evidence for IV Iron Treatment Outcomes in Patients with Heart Failure?

  • 

    

    Giuseppe M.C. Rosano, MD, PhD, FESC, FHFA

    Peer

  • 

    

    Antoni Bayés-Genís, MD, PhD, FESC, FHFA

    Peer

  • 

    

    Ovidiu Chioncel, MD, PhD

    Peer

  • 

    

    Marco Metra, MD

    Peer

  0.50 credits

• 

  CME/CE Meeting

  NASH: An Epidemic with Significant Implications for Managed Care Professionals

  October 18, 2023

  06:00 PM - 08:00 PM EDT

  • 

    

    Zobair M Younossi MD, MPH, FACP, FACG, AGAF, FAASLD

    Peer

  • 

    

    Naim Alkhouri, MD

    Peer

  • 

    

    Kathleen E. Corey, MD, MPH

    Peer

  1.50 credits Learn more

• 

  RestartResume

  A Closer Look at Real-World Strategies for Treatment-Resistant DME

  MinuteCE®

  A Closer Look at Real-World Strategies for Treatment-Resistant DME

  • 

    

    Durga Borkar, MD, MMCi

    Peer

  • 

    

    Christina Y. Weng, MD, MBA

    Peer

  1.00 program credits

• 

  RestartResume

  A Quick Look at Standard Treatments for Sickle Cell Disease

  MinuteCE®

  A Quick Look at Standard Treatments for Sickle Cell Disease

  • 

    

    Biree Andemariam, MD

    Peer

  • 

    

    Caroline Freiermuth, MD

    Peer

  1.00 program credits